DSM Nutritional Products, Inc.; Filing of Color Additive Petition, 68166-68167 [E7-23473]
Download as PDF
<![CDATA[
68166
Federal Register / Vol. 72, No. 232 / Tuesday, December 4, 2007 / Notices
By accepting the Consent Agreement
subject to final approval, the
Commission anticipates that the
competitive problems alleged in the
Complaint will be resolved. The
purpose of this analysis is to invite
public comment on the Consent Order,
including the proposed divestitures, to
aid the Commission in its determination
whether it should make final the
Consent Agreement. This analysis is not
an official interpretation of the Consent
Agreement nor does it modify any of its
terms.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. E7–23419 Filed 12–3–07: 8:45 am]
BILLING CODE 6750–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request Proposed
Project
Title: Building Strong Families (BSF)
Demonstration and Evaluation—Impact
Study Second Follow-up.
OMB No.: New Collection.
Description: The Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is proposing a data
collection activity as part of the
Building Strong Families (BSF)
Demonstration and Evaluation. The
proposed collection will consist of two
elements: (1) A telephone survey to be
administered to both partners in couples
enrolled in the BSF research sample
about 36 months after enrollment, and
(2) observational assessments of BSF
families and their children.
These data collections are part of the
BSF evaluation, which is an important
opportunity to learn if well-designed
interventions can help low-income
couples develop the knowledge and
relationship skills that research has
shown are associated with healthy
marriages. BSF programs provide
instruction and support to improve
marriage and relationship skills and
enhance couples’ understanding of
marriage. In addition, BSF programs
provide links to a variety of other
services that could help couples sustain
a healthy relationship (e.g., employment
assistance). The BSF evaluation uses an
experimental design that randomly
assigns couples who volunteer to
participate in BSF programs to a
program or to a control group.
The 36-month data collection effort
draws heavily from the 15-month survey
conducted in BSF sites. Materials for the
15-month data collection effort were
previously submitted to OMB and were
approved under OMB Control No. 0970–
0304.
Respondents: The respondents for the
telephone questionnaire will be all
couples in the BSF evaluation. The
respondents for the observational
assessments will be a sub-sample of
children of the couples.
ANNUAL BURDEN ESTIMATES
Annual
number of
respondents
Instrument
mstockstill on PROD1PC66 with NOTICES
36-month telephone survey (female partner)
36-month telephone survey (male partner) ....
Child/family observations ................................
Estimated Total Annual Burden
Hours: 4,322.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on (a) whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
VerDate Aug<31>2005
18:12 Dec 03, 2007
Jkt 214001
Number of
responses per
respondent
2,099
1,978
1,125
1
1
1
Average burden hours per response
Estimated
annual
burden hours
.9166666 (55 minutes) ...................................
.8333333 (50 minutes) ...................................
.6666666 (40 minutes) ...................................
1,924
1,648
750
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: November 26, 2007.
Brendan C. Kelly,
OPRE Reports Clearance Officer.
[FR Doc. 07–5916 Filed 12–03–07; 8:45 am]
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that DSM Nutritional Products, Inc., has
filed a petition proposing that the color
additive regulations be amended to
provide for the safe use of astaxanthin
dimethyldisuccinate as a color additive
in the feed of salmonid fish to enhance
the color of their flesh.
FOR FURTHER INFORMATION CONTACT:
Felicia M. Ellison, Center for Food
Safety and Applied Nutrition (HFS–
265), Food and Drug Administration,
BILLING CODE 4184–01–M
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Food and Drug Administration
[Docket No. 2007N–0453]
DSM Nutritional Products, Inc.; Filing
of Color Additive Petition
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
E:\FR\FM\04DEN1.SGM
Notice.
04DEN1
Federal Register / Vol. 72, No. 232 / Tuesday, December 4, 2007 / Notices
5100 Paint Branch Pkwy., College Park,
MD 20740–3835, 301–436–1264.
SUPPLEMENTARY INFORMATION: Under the
Federal Food, Drug, and Cosmetic Act
(section 721e(d)(1) (21 U.S.C.
379e(d)(1))), notice is given that a color
additive petition (CAP 7C0284) has been
filed by DSM Nutritional Products, Inc.,
45 Waterview Blvd., Parsippany, NJ
07054. The petition proposes to amend
the color additive regulations in 21 CFR
part 73 to provide for the safe use of
astaxanthin dimethyldisuccinate as a
color additive in the feed of salmonid
fish to enhance the color of their flesh.
The agency has determined under 21
CFR 25.32(r) that this action is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
Dated: November 27, 2007.
Laura M. Tarantino,
Director, Office of Food Additive Safety,
Center for Food Safety and Applied Nutrition.
[FR Doc. E7–23473 Filed 12–3–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Allergy and
Infectious Diseases; Notice of Closed
Meeting
mstockstill on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Organ Specific Innate
Immunity.
Date: December 17, 2007.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Room 3146, Bethesda, MD 20817 (Telephone
Conference Call).
VerDate Aug<31>2005
17:38 Dec 03, 2007
Jkt 214001
Contact Person: Kenneth E. Santora, PhD.,
Scientific Review Officer, Scientific Review
Program, NIH/NIAID/DHHS, Room 3146,
6700B Rockledge Drive, MSC 7616, Bethesda,
MD 20892, 301–451–2605, ks216i@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitation imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 26, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5909 Filed 12–3–07; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, MBRS—RISE and SCORE.
Date: December 11, 2007.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Lisa Dunbar, PhD., Office
of Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN12,
Bethesda, MD 20892, 301–594–2849,
dunbarl@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Frm 00046
Fmt 4703
Physiology, and Biological Chemistry
Research; 93.862, Genetics and Development
Biology Research; 93.88, Minority Access to
Research Careers; 93.96, Special Minority
Initiatives, National Institutes of Health,
HHS)
Dated: November 26, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5910 Filed 12–3–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
BILLING CODE 4140–01–M
PO 00000
68167
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Mental Health
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Mental Health Council.
Date: January 10–11, 2008.
Closed: January 10, 2008, 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and review the activities of the
NIMH; Intramural Research Programs.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room C/D/E,
Rockville, MD 20852.
Open: January 11, 2008, 8:30 a.m. to 12:30
p.m.
Agenda: Presentation of NIMH Director’s
report and discussion on NIMH program and
policy issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing, 6th
Floor, Conference Room 6, Bethesda, MD
20892.
Contact Person: Jane A. Steinberg, PhD,
Director, Division of Extramural Activities,
E:\FR\FM\04DEN1.SGM
04DEN1
]]>Agencies
[Federal Register Volume 72, Number 232 (Tuesday, December 4, 2007)]
[Notices]
[Pages 68166-68167]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-23473]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007N-0453]
DSM Nutritional Products, Inc.; Filing of Color Additive Petition
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that DSM
Nutritional Products, Inc., has filed a petition proposing that the
color additive regulations be amended to provide for the safe use of
astaxanthin dimethyldisuccinate as a color additive in the feed of
salmonid fish to enhance the color of their flesh.
FOR FURTHER INFORMATION CONTACT: Felicia M. Ellison, Center for Food
Safety and Applied Nutrition (HFS-265), Food and Drug Administration,
[[Page 68167]]
5100 Paint Branch Pkwy., College Park, MD 20740-3835, 301-436-1264.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (section 721e(d)(1) (21 U.S.C. 379e(d)(1))), notice is given that a
color additive petition (CAP 7C0284) has been filed by DSM Nutritional
Products, Inc., 45 Waterview Blvd., Parsippany, NJ 07054. The petition
proposes to amend the color additive regulations in 21 CFR part 73 to
provide for the safe use of astaxanthin dimethyldisuccinate as a color
additive in the feed of salmonid fish to enhance the color of their
flesh.
The agency has determined under 21 CFR 25.32(r) that this action is
of a type that does not individually or cumulatively have a significant
effect on the human environment. Therefore, neither an environmental
assessment nor an environmental impact statement is required.
Dated: November 27, 2007.
Laura M. Tarantino,
Director, Office of Food Additive Safety, Center for Food Safety and
Applied Nutrition.
[FR Doc. E7-23473 Filed 12-3-07; 8:45 am]
BILLING CODE 4160-01-S
